| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13726* | 2021 |
| Towards tuberculosis elimination: an action framework for low-incidence countries K Lönnroth, GB Migliori, I Abubakar, L D'Ambrosio, G De Vries, R Diel, ... European Respiratory Journal 45 (4), 928-952, 2015 | 906 | 2015 |
| LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement U Mack, GB Migliori, M Sester, HL Rieder, S Ehlers, D Goletti, A Bossink, ... European Respiratory Journal 33 (5), 956-973, 2009 | 854 | 2009 |
| Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis R Diel, D Goletti, G Ferrara, G Bothamley, D Cirillo, B Kampmann, ... European Respiratory Journal 37 (1), 88-99, 2010 | 779 | 2010 |
| Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis M Sester, G Sotgiu, C Lange, C Giehl, E Girardi, GB Migliori, A Bossink, ... European Respiratory Journal 37 (1), 100-111, 2010 | 764 | 2010 |
| Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. D Goletti, D Weissman, RW Jackson, NM Graham, D Vlahov, RS Klein, ... Journal of immunology (Baltimore, Md.: 1950) 157 (3), 1271-1278, 1996 | 727 | 1996 |
| The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement I Solovic, M Sester, JJ Gomez-Reino, HL Rieder, S Ehlers, HJ Milburn, ... European Respiratory Journal 36 (5), 1185-1206, 2010 | 612 | 2010 |
| Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases M Tadolini, LR Codecasa, JM García-García, FX Blanc, S Borisov, ... European Respiratory Journal 56 (1), 2020 | 540 | 2020 |
| Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact F Cantini, L Niccoli, D Matarrese, E Nicastri, P Stobbione, D Goletti The Journal of infection 81 (2), 318, 2020 | 518 | 2020 |
| Control of SHIV-89.6 P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine A Cafaro, A Caputo, C Fracasso, MT Maggiorella, D Goletti, S Baroncelli, ... Nature medicine 5 (6), 643-650, 1999 | 378 | 1999 |
| Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects D Visca, CWM Ong, S Tiberi, R Centis, L D’ambrosio, B Chen, J Mueller, ... Pulmonology 27 (2), 151-165, 2021 | 350 | 2021 |
| MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment A Dorhoi, M Iannaccone, M Farinacci, KC Faé, J Schreiber, ... The Journal of clinical investigation 123 (11), 4836-4848, 2013 | 328 | 2013 |
| Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis S Minozzi, S Bonovas, T Lytras, V Pecoraro, M Gonzalez-Lorenzo, ... Expert opinion on drug safety 15 (sup1), 11-34, 2016 | 316 | 2016 |
| ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells A Romagnoli, MP Etna, E Giacomini, M Pardini, ME Remoli, M Corazzari, ... Autophagy 8 (9), 1357-1370, 2012 | 307 | 2012 |
| The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement D Bumbacea, SM Arend, F Eyuboglu, JA Fishman, D Goletti, MG Ison, ... European Respiratory Journal 40 (4), 990-1013, 2012 | 304 | 2012 |
| Use of a T cell–based assay for monitoring efficacy of antituberculosis therapy S Carrara, D Vincenti, N Petrosillo, M Amicosante, E Girardi, D Goletti Clinical Infectious Diseases 38 (5), 754-756, 2004 | 301 | 2004 |
| Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts I Motta, R Centis, L D’Ambrosio, JM García-García, D Goletti, G Gualano, ... Pulmonology 26 (4), 233-240, 2020 | 274 | 2020 |
| Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020 GB Migliori, PM Thong, O Akkerman, JW Alffenaar, F Álvarez-Navascués, ... Emerging infectious diseases 26 (11), 2709, 2020 | 252 | 2020 |
| MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network GB Migliori, S Tiberi, A Zumla, E Petersen, JM Chakaya, C Wejse, ... International Journal of Infectious Diseases 92, S15-S25, 2020 | 250 | 2020 |
| Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi’s sarcoma P Monini, S Colombini, M Sturzl, D Goletti, A Cafaro, C Sgadari, S Butto, ... Blood, The Journal of the American Society of Hematology 93 (12), 4044-4058, 1999 | 238 | 1999 |
Enrico GirardiDirector Epidemiology, INMI Spallanzani, Rome, ItalyBestätigte E-Mail-Adresse bei inmi.it